Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review

BACKGROUND: Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control with drugs may reduce long-term CVD risk. Bromocriptine has been in clinical use for over 30 years, but the utility of brom...

Descripción completa

Detalles Bibliográficos
Autores principales: Birhan, Mulualem Tesfaye, Ayele, Teklie Mengie, Abebe, Fikire Wondimu, Dgnew, Fiseha Nigussie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324265/
https://www.ncbi.nlm.nih.gov/pubmed/37415177
http://dx.doi.org/10.1186/s13098-023-01073-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324265/
https://www.ncbi.nlm.nih.gov/pubmed/37415177
http://dx.doi.org/10.1186/s13098-023-01073-2

Ejemplares similares